
Tonix Pharmaceuticals Holding Corp. TNXP
$ 14.14
1.16%
Quarterly report 2025-Q3
added 11-10-2025
Tonix Pharmaceuticals Holding Corp. Long Term Debt Current 2011-2026 | TNXP
Annual Long Term Debt Current Tonix Pharmaceuticals Holding Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 270 K | 432 K | 489 K | 595 K | 352 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 595 K | 270 K | 428 K |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
7.09 M | $ 20.41 | -1.4 % | $ 2.57 B | ||
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.79 | -6.51 % | $ 4.31 M | ||
|
Axsome Therapeutics
AXSM
|
434 K | $ 165.07 | -0.79 % | $ 8.21 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.76 | -1.7 % | $ 1.12 B | ||
|
Corvus Pharmaceuticals
CRVS
|
1.37 M | $ 18.11 | 1.23 % | $ 870 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Capricor Therapeutics
CAPR
|
749 K | $ 26.36 | -1.82 % | $ 706 M | ||
|
Certara
CERT
|
3.92 M | $ 7.24 | 2.62 % | $ 1.16 B | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
2.83 M | $ 1.01 | -0.98 % | $ 74.1 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
437 K | $ 23.77 | -0.46 % | $ 2.91 B | ||
|
Agenus
AGEN
|
2.59 M | $ 3.27 | -2.09 % | $ 1.17 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
18.4 M | $ 28.85 | -1.2 % | $ 1.67 B | ||
|
Champions Oncology
CSBR
|
1.47 M | $ 5.98 | -1.48 % | $ 81.7 M | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Cellectis S.A.
CLLS
|
8.38 M | $ 3.71 | -2.43 % | $ 116 M | ||
|
Alector
ALEC
|
9.06 M | $ 2.13 | -3.39 % | $ 219 M | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
279 K | $ 4.22 | 1.32 % | $ 300 M | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Amarin Corporation plc
AMRN
|
2.15 M | $ 14.3 | 2.66 % | $ 5.93 B | ||
|
AbbVie
ABBV
|
194 M | $ 233.44 | -0.33 % | $ 413 B |